Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V8 in Treating Kidney Failure
NCT04377243Phase 2Unknown
- Sponsor
- Immunitor Inc.
- Start
- Jun 2020
- Primary completion
- May 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of V8 in chronic kidney disease (CKD), sponsored by Immunitor Inc.. Status: unknown.
02
Drugs
V8
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04377243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377243.